Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor


The fibrinogen (Fbg) molecule is a dimer, consisting of three pairs of different polypeptide chains. In the coagulation cascade, Fbg is converted into fibrin. It is an acute phase protein that is involved in several cellular interactions:platelet aggregation, blood rheology, pinocytosis, cell growth, cell migration, chemotaxis and endothelial cell injury. Fibrinogen biosynthesis by hepatocytes is controlled by "hepatocyte stimulating factors" (Interleukin-6, Leukemia Inhibitor Factor and Oncostatin M). Several epidemiological studies have demonstrated a positive statistical correlation of the plasma Fbg level with subsequent ischemic cardiovascular events. Fbg is associated with cholesterol, glycemia, blood pressure, smoking, alcohol, age. It has not been clearly established whether the increase in Fbg levels is a risk factor or merely a marker of vascular desease.


Documento: Artículo
Título:Fibrinógeno. ¿Factor de riesgo o marcador de enfermedad vascular?
Autor:Quintana, I.L.
Filiación:Licenciada en Ciencias Quimicas, Fac. de Cie., Exactas y Naturales, Universidad de Buenos Aires, Argentina
Palabras clave:Atherosclerosis; Fibrinogen; Marker of activation; Risk factor
Página de inicio:13
Página de fin:22
Título revista:Acta Bioquimica Clinica Latinoamericana
Título revista abreviado:Acta Bioquim. Clin. Latinoam.


  • Holm, B., Bosstad, F., Kierulf, P., Godal, H., Polimerization properties of two normally circulating, HMW and LMW. Evidence that the COOH-terminal end of the α-chain is of importance for fibrin polimerization (1985) Thromb. Res., 39, pp. 595-606
  • Fu, Y., Weissbach, L., Plant, P., Oddux, C., Cao, Y., Liang, T., Roy, S., Grieninger, G., Carboxi-terminal-extended variant of the human fibrinogen a subunit: A novel exon marked homology to β and γ subunits (1992) Biochemistry, 31, pp. 11968-11972
  • Blomback, B., Fibrinogen structure, activation, polymerization and fibrin gel structure (1994) Thromb. Res., 75 (3), pp. 327-328
  • Townsend, R., Hilliker, E., Li, Y., Carbohydrate structure of human fibrinogen (1982) J. Biol. Chem., 257, pp. 9704-9708
  • Fowler, W., Erickson, H., Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy (1979) J. Mol. Biol., 134, pp. 241-246
  • Doolittle, R., Fibrinogen and fibrin (1994) Sci. Am., 245, pp. 92-101
  • Hermans, J., Mcdonagh, J., Fibrin: Structure and interactions (1982) Sem. Thromb. Hemost., 8, pp. 11-24
  • Pisano, J., Finlayson, J., Peyton, M., Cross-link fibrin polymerized by factor XIII (γ-glutamyl) lysine (1968) Science, 160, pp. 892-895
  • Di Minno, G., Mancini, M., Measuring plasma fibrinogen to predict stroke and miocardial infarction (1990) Atherosclerosis, 10, pp. 1-7
  • Barnhart, M., Cress, D., Noonan, S., Walsh, R., Influence of fibrinolytic products on hepatic release and synthesis of fibrinogen (1970) Thromb. Haemost. Suppl., 39, pp. 143-159
  • Louache, F., Fibrinogen is not synthetisez by human megakaryocytes (1991) Blood, 77 (2), pp. 311-316
  • Lange, W., Luig, A., Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes (1991) Blood, 78 (1), pp. 20-25
  • Cratree, G., Comeau, C., Fowlkes, D., Nace, A., Malley, J., Kant, J., Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? (1985) J. Biol. Chem., 185, pp. 1-19
  • Yu, S., Sher, B., Kudryk, B., Redman, C., Intracellular assembly of human fibrinogen? (1983) J. Biol. Chem., 258, pp. 13407-13410
  • Collen, D., Tytgat, G., Claeys, H., Piessens, R., Metabolism and distribution of fibrinogen (1972) Br. J. Haematol., 22, pp. 681-699
  • Martinez, J., Holburn, R., Shapiro, S., Erslev, A., Fibrinogen Philadelphia (1974) J. Clin. Investig., 53, pp. 600-611
  • Morell, A., Gregoriadis, G., Scheinberg, I., The role of sialic acid in determing the survival of glycoproteins in the circulation (1971) J. Biol. Chem., 246, pp. 1461-1465
  • Mcfarlane, A., Todd, D., Cromwell, S., Fibrinogen catabolism humans (1964) Clin. Sci., 26, pp. 415-420
  • Roy, S., Yu, S., Banerjee, D., Overtom, O., Assembly and secretion of fibrinogen. Degradation of individual chains (1992) J. Biol. Chem., 267 (32), pp. 23151-23158
  • Hamsten, A., Iselius, L., De Faire, U., Blomback, M., Genetic and cultural inheritance of plasma fibrinogen concentration (1987) Lancet, 2, pp. 988-990
  • Margaglione, M., Di Minno, G., Grandone, E., Raised plasma fibrinogen concentrations in subjets attending a metabolic ward. Relation to family history and vascular risk factors (1995) Thromb. Haemostas., 73, pp. 579-583
  • Heinrich, J., Funke, H., Rust, S., Impact of polymorphins in the alpha- And betha-fibrinogen gene on plasma fibrinogen concentrations of coronary disease patients (1995) Thromb. Res., 77, pp. 209-215
  • Unwin, N., Harland, J., Fisher, W., The epidemiology of fibrinogen in a UK Chinese population (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 6. , Abst. 0-14
  • Iso, H., Folsom, A., Winkelmann, J., Polymorphins of the beta fibrinogen gen and plasma fibrinogen concentration in Caucasian and Japanese population samples (1995) Thromb. Haemostas., 73, pp. 106-111
  • Folsom, A., Wu, K., Epidemiology of plasma fibrinogen (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 7. , Abst. 0-16
  • Iso, H., Folsom, A., Sato, S., Wu, K., Shimamoto, T., Koike, K., Iida, M., Komachi, I., Plasma fibrinogen and its correlates in Japanese and US population samples (1993) Arterioscler. Thromb., 13, pp. 783-790
  • Van Der Bom, J., Bots, M., Grobbee, D., Seasonal variations of plasma fibrinogen and leukocytes are dissociated in the Rotterdam Study (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), pp. 8-9
  • Stout, R., Crawford, V., Seasonal variations in fibrinogen concentrations among elderly people (1991) Lancet, 338, pp. 9-13
  • Eliasson, M., Ervin, P., Lundblad, D., Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. A population study (1993) Fibrinolysis, 7, pp. 316-323
  • Balleisen, L., Bailey, J., Epping, P., Epidemiological study on factor VII and fibrinogen in an industrial population: Baseline data on relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause (1985) Thromb. Haemostas., 54, pp. 475-479
  • Maseri, A., Biasucci, L., Andreotti, F., Age dependence of ischaemic heart syndromes and the contribution of haemostatic deviations (1992) Fibrinolysis, 6 (3 SUPPL.), pp. 3-4
  • Haverkate, F., Thomson, S., Duckest, F., Haemostasis factors in angina pectoris: Relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group (1995) Thromb. Haemostas., 73, pp. 561-567
  • Rosengrem, A., Wilhelmsen, L., Fibrinogen and coronary heart disease in smokers and no smokers. the study of men born in 1933 (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 10. , Abst. 0-23
  • Jern, C., Eriksson, E., Tengborn, L., Changes of plasma coagulation and fibrinolysis in response to mental stress (1989) Thromb. Haemostas., 62, pp. 767-771
  • Lee, A., Flanagan, P., Rumley, F., Relationship between alcohol intake and tissue plasminogen activator antigen and other haemostatic factors in the general population (1995) Fibrinolysis, 9, pp. 49-54
  • Oousthizen, W., Vorster, H., Herling, L., Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels (1994) Thromb. Haemostas., 72 (4), pp. 557-562
  • Elwood, P., Yarnell, J., Pickering, J., Fehily, A., O'Brien, J., Exercise, fibrinogen and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study (1993) Br. Heart J., 69 (2), pp. 183-187
  • Pechetl, A., Alexander, B., Increased clotting factors in pregnancy (1961) N. Engl. J. Med., 265, pp. 1093-1095
  • Scarabin, P., Plu-Bureau, G., Bara, L., Haemostatic variables and menopausal status: Influence of hormonr replacement therapy (1993) Thromb. Haemost., 70, pp. 584-587
  • Downtown, S., Goten, H., Acute phase reactants in inflamation and infection (1988) Sem. Hematol., 25, pp. 84-90
  • Amrani, D., Regulation of fibrinogen biosyntesis: Glucocorticoid and interleikin-6 con- Trol (1990) Blood Coag. Fibrin., 1, pp. 443-446
  • Lechner, K., Niesser, H., Thaler, E., Coagulation abnormalities in liver disease (1977) Semi. Thromb. Hemos., 40, pp. 40-45
  • Berglund, U., Wallentin, L., Von Schenck, H., Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction (1988) Thromb. Haemostas., 60, pp. 21-24
  • Mazoyer, E., Ripoll, L., Boisseau, M., Drouet, L., How does ticlopidine lower plasma fibrinogen (1994) Thromb. Res., 75 (3), pp. 361-370
  • Gralnick, H., Henderson, E., Hypofibrinogenemia and coagulation factor deficiencies with 1-asparaginase treatment (1971) Cancer, 27, pp. 1.313-1.316
  • Meade, T., Imeson, Stirling, Y., Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease (1987) Lancet, 2, pp. 986-988
  • Wilhelmsen, L., Svarsudd, K., Korsan Bengtsen, K., Larson, B., Wellin, L., Tibblin, G., Fibrinogen as a risk factor for stroke and myocardial infarction (1984) N. Engl. J. Med., 311, pp. 501-505
  • Ridker, P., Hennekens, C., Hemostatic risk factor for coronary heart disease (1991) Circulation, 83, pp. 1.098-1.100
  • Qizilbash, N., Fibrinogen and cerebrovascular disease: An overview (1994) Blood Coag. Fibrin., 5 (2 SUPPL.), p. 14. , Abst. 0-31
  • Meade, T., Chakarabarti, R., Haemostatic function and cardiovascular death: Early results of a prospective study (1980) Lancet, 2, pp. 1.050-1.053
  • Meade, T., Brozovic, M., Chakrabarti, R., Haemostatic function and ischaemic heart disease: Principal results of Northwick Park Heart Study (1986) Lancet, 2, pp. 533-533
  • Wihelmsen, L., Svarsudd, K., Korsan-Bentsen, K., Fibrinogen as a risk factor for stroke and myocardial infarction (1984) N. Eng. J. Med., 311, pp. 501-505
  • Kannel, W., Wolf, P., Castelli, W., D'Agostino, R., Fibrinogen and risk of cardiovascular disease", the Framingham Study (1987) JAMA, 258, pp. 1.183-1.186
  • Heinrich, J., Schulte, H., Balleisen, L., Predictive value of haemostatic variables in the PROCAM study (1991) Thromb. Haemostas., 65, p. 815. , Abst. 466
  • Fowkes, F., Fibrinogen and peripheral arterial disease (1995) Eur. Heart J., 16 (SUPPL. A), pp. 36-40
  • Meade, T., Fibrinogen is ischaemic heart disease (1995) Eur. Heart. J., 16 (SUPPL. A), pp. 31-34
  • Eber, B., Schumacher, M., Fibrinogen: Its role in the hemostatic regulation in atherosclerosis (1993) Sem. Thromb. Hemos., 19 (2), pp. 104-107
  • Yarnell, Y., Mccrum, E., Evans, A., Determinants of plasma fibrinogen and viscosity: Gender differences in the Belfast MONICA Surveys and in the other MONICA populations (1994) Blood Clog. Fibrin., 5 (2 SUPPL.), pp. 6-7
  • Yarnell, Y., Baker, I., Sweetnam, P., Fibrinogen, viscosity and white blood cell count are major riskfactors for ischemic heart disease. the Caerphilly and Speedwell Collaborative Heart Disease Studies (1991) Circulation, 83, pp. 836-844
  • Blomback, B., Okada, M., Fibrin gel structure and clotting time (1982) Thromb. Res., 25, pp. 51-70
  • Blomback, B., Carlsson, K., Fatah, K., Hessel, B., Procyk, R., Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation (1994) Thromb. Res., 75, pp. 521-538
  • Fatah, K., Hamsten, A., Blomback, B., Blomback, M., Fibrin gel network characteristics and coronary heart disease: Relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis (1992) Thromb. Haemostas., 68, pp. 130-135
  • Mcdonagh, J., Suppressin of plasminogen binding to fibrin by high fibrinogen: A mechanism for how fibrinogen enhances the risk of thrombosis (1994) Thrombosis, 4, pp. I-XX
  • Vasse, M., Collet, J., Soria, J., Mirshashi, S., Vannier, J., Soria, C., Fibrinogen, a vascular risk factor: A simple marker or a real cause of vascular lesion (1994) Thromb. Res., 75 (3), pp. 349-352
  • Smith, E., Thompson, W., Fibrin as a factor in atherogenesis (1994) Thromb Res., 73, pp. 1-19
  • Vasse, M., Mirshahi, S., Soria, J., Mirshahi, M., Borg, J., Monconduit, M., Soria, C., Potent activity of peripheral blood lymphocytes in inducing hepaticyte stimulating factor and urokinase in monocytes (1993) Blood Coag. and Fibrin., 4, pp. 143-147


---------- APA ----------
(1998) . Fibrinógeno. ¿Factor de riesgo o marcador de enfermedad vascular?. Acta Bioquimica Clinica Latinoamericana, 32(1), 13-22.
Recuperado de [ ]
---------- CHICAGO ----------
Quintana, I.L. "Fibrinógeno. ¿Factor de riesgo o marcador de enfermedad vascular?" . Acta Bioquimica Clinica Latinoamericana 32, no. 1 (1998) : 13-22.
Recuperado de [ ]
---------- MLA ----------
Quintana, I.L. "Fibrinógeno. ¿Factor de riesgo o marcador de enfermedad vascular?" . Acta Bioquimica Clinica Latinoamericana, vol. 32, no. 1, 1998, pp. 13-22.
Recuperado de [ ]
---------- VANCOUVER ----------
Quintana, I.L. Fibrinógeno. ¿Factor de riesgo o marcador de enfermedad vascular?. Acta Bioquim. Clin. Latinoam. 1998;32(1):13-22.
Available from: [ ]